SCHEDULE: Millennium Group and Israel Englander Report 2.1% Stake in GoodRx Holdings

Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander jointly report beneficial ownership of 2,186,869 shares of GoodRx Holdings, Inc., representing 2.1% of the company's Class A Common Stock.

Summary

• Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander have filed a Schedule 13G, indicating their joint beneficial ownership of GoodRx Holdings, Inc. Class A Common Stock.
• The filing reports that they collectively own 2,186,869 shares, which represents 2.1% of the outstanding Class A Common Stock.
• The shares are held by entities subject to voting control and investment discretion by Millennium Management LLC and/or other investment managers controlled by Millennium Group Management LLC and Mr. Englander.
• The filing confirms that the securities were not acquired to influence control of the issuer.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing and does not contain any information that would indicate a positive or negative sentiment. It is a neutral disclosure of ownership.

Positives

• The filing indicates a significant investment by a well-known investment firm and its principals.
• The reported ownership is a clear and transparent disclosure of their stake in GoodRx Holdings, Inc.

Risks

• The filing does not provide any information about the investment strategy or future intentions of the reporting parties.
• The ownership stake is relatively small and may not have a significant impact on the company's operations or strategy.

Industry Context

This filing is a standard disclosure for investors who acquire more than 5% of a company's stock, or in this case, a group that has acquired more than 5%. It indicates the level of institutional interest in GoodRx Holdings, Inc. and is a common occurrence in the financial markets.

Comparison to Industry Standards

• Schedule 13G filings are a standard practice for investors who acquire a significant stake in a publicly traded company.
• The 2.1% ownership stake is relatively small compared to other institutional investors, but it is still a notable position.
• Other investment firms such as BlackRock, Vanguard, and State Street often file similar reports when their ownership crosses the 5% threshold.

Stakeholder Impact

• The filing provides transparency to shareholders regarding the ownership structure of GoodRx Holdings, Inc.
• The investment by Millennium Management and Israel Englander could be viewed positively by the market.

Key Dates

Keywords

GoodRx Holdings, Millennium Management, Israel Englander, Schedule 13G, Beneficial Ownership, Class A Common Stock, Investment